PI
UTHR icon

Putnam Investments’s United Therapeutics UTHR Stock Holding History

Putnam Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-37,900
Closed -$10.5M – 1213
2022
Q4 		$10.5M Buy
+37,900
New +$9.57M 0.02% 275
2022
Q1 		– Sell
-88,875
Closed -$19.2M – 1261
2021
Q4 		$19.2M Hold
88,875
– – 0.03% 260
2021
Q3 		$16.4M Hold
88,875
– – 0.03% 276
2021
Q2 		$15.9M Buy
88,875
+38,316
+76% +$7.3M 0.02% 289
2021
Q1 		$8.46M Buy
+50,559
New +$8.43M 0.01% 405
2017
Q2 		– Sell
-39,175
Closed -$5.3M – 1296
2017
Q1 		$5.3M Sell
39,175
-100
-0.3% -$15.1K 0.01% 563
2016
Q4 		$5.63M Hold
39,275
– – 0.01% 541
2016
Q3 		$4.64M Buy
39,275
+100
+0.3% +$12K 0.01% 591
2016
Q2 		$4.15M Sell
39,175
-12,315
-24% -$1.37M 0.01% 713
2016
Q1 		$5.74M Sell
51,490
-486,030
-90% -$61.5M 0.01% 578
2015
Q4 		$84.2M Sell
537,520
-117,266
-18% -$17.1M 0.19% 119
2015
Q3 		$85.9M Buy
654,786
+26,457
+4% +$4.24M 0.19% 124
2015
Q2 		$109M Buy
628,329
+512,470
+442% +$92.2M 0.22% 103
2015
Q1 		$20M Buy
115,859
+75,833
+189% +$11.6M 0.04% 348
2014
Q4 		$5.18M Sell
40,026
-98,556
-71% -$12.7M 0.01% 766
2014
Q3 		$17.8M Buy
138,582
+900
+0.7% +$92.8K 0.04% 350
2014
Q2 		$12.2M Buy
+137,682
New +$13.2M 0.03% 428
2014
Q1 		– Sell
-5,938
Closed -$672K – 1529
2013
Q4 		$672K Sell
5,938
-88,854
-94% -$8.01M ﹤0.01% 1283
2013
Q3 		$7.47M Buy
94,792
+658
+0.7% +$48.1K 0.02% 537
2013
Q2 		$6.2M Buy
+94,134
New +$6.06M 0.02% 589

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Putnam Investments's UTHR Position: Q1 2023 in Review

Putnam Investments sold out of United Therapeutics (UTHR) in Q1 2023, closing a stake of 37,900 shares — an estimated $10.5M sold.

Putnam Investments first reported a position in UTHR in Q2 2013 and held it in 20 quarters. The position peaked at $109M in Q2 2015. 506 funds tracked by Wall St. Rank hold UTHR as of Q1 2023.

  • Putnam Investments reported no remaining United Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Putnam Investments sold 37,900 United Therapeutics shares in Q1 2023, an estimated $10.5M.
  • Putnam Investments first reported a position in United Therapeutics in Q2 2013 and held it in 20 quarters.
  • Putnam Investments's United Therapeutics position peaked at $109M in Q2 2015.
  • 506 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2023.

Based on Putnam Investments's 13F filing for Q1 2023, filed 22 May 2023.